CpG protects human monocytic cells against HIV-Vpr-induced apoptosis by cellular inhibitor of apoptosis-2 through the calcium-activated JNK pathway in a TLR9-independent manner

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 5865-5878

  Saxena, Mansi ^a   Busca, Aurelia ^a   Pandey, Sunita ^b   Kryworuchko, Marko ^a,b,c   Kumar, Ashok ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CPG OLIGODEOXYNUCLEOTIDE; INHIBITOR OF APOPTOSIS PROTEIN 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 9; VPR PROTEIN;

APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICROSCOPY, CONFOCAL; MONOCYTES; OLIGONUCLEOTIDES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; TRANSFECTION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 82755190057     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100115     Document Type: Article

References (77)

1. Mahlknecht, U., and G. Herbein. 2001. Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells? Trends Immunol. 22: 256-260. (Pubitemid 32667513)
2. Almodóvar, S., M. Del C Colón, I. M. Maldonado, R. Villafañe, S. Abreu, I. Meléndez, C. Domaposnguez, W. Cuevas, T. M. Collins, and E. Lorenzo. 2007. HIV-1 infection of monocytes is directly related to the success of HAART. Virology 369: 35-46. (Pubitemid 350047472)
3. Ellery, P. J., E. Tippett, Y. L. Chiu, G. Paukovics, P. U. Cameron, A. Solomon, S. R. Lewin, P. R. Gorry, A. Jaworowski, W. C. Greene, et al. 2007. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV- 1 in vivo. J. Immunol. 178: 6581-6589. (Pubitemid 46717442)
4. Lum, J. J., A. A. Pilon, J. Sanchez-Dardon, B. N. Phenix, J. E. Kim, J. Mihowich, K. Jamison, N. Hawley-Foss, D. H. Lynch, and A. D. Badley. 2001. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l. J. Virol. 75: 11128-11136. (Pubitemid 33031579)
5. Alhetheel, A., Y. Yakubtsov, K. Abdkader, N. Sant, F. Diaz-Mitoma, A. Kumar, and M. Kryworuchko. 2008. Amplification of the signal transducer and activator of transcription I signaling pathway and its association with apoptosis in monocytes from HIV-infected patients. AIDS 22: 1137-1144.
6. Cui, M., Y. Huang, Y. Zhao, and J. Zheng. 2008. Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages. J. Immunol. 180: 898-906.
7. Huang, Y., N. Erdmann, H. Peng, S. Herek, J. S. Davis, X. Luo, T. Ikezu, and J. Zheng. 2006. TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation. J. Immunol. 177: 2304-2313. (Pubitemid 44200990)
8. Guillemard, E., C. Jacquemot, F. Aillet, N. Schmitt, F. Barré-Sinoussi, and N. Israël. 2004. Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF. Virology 329: 371-380. (Pubitemid 39423986)
9. Garaci, E., M. C. Caroleo, L. Aloe, S. Aquaro, M. Piacentini, N. Costa, A. Amendola, A. Micera, R. Caliò, C. F. Perno, and R. Levi-Montalcini. 1999. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc. Natl. Acad. Sci. USA 96: 14013-14018.
10. Papasavvas, E., J. Sun, Q. Luo, E. C. Moore, B. Thiel, R. R. MacGregor, A. Minty, K. Mounzer, J. R. Kostman, and L. J. Montaner. 2005. IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytes. J. Immunol. 175: 5532-5540. (Pubitemid 41456441)
11. Henklein, P., K. Bruns, M. P. Sherman, U. Tessmer, K. Licha, J. Kopp, C. M. de Noronha, W. C. Greene, V. Wray, and U. Schubert. 2000. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J. Biol. Chem. 275: 32016-32026.
12. Jowett, J. B., V. Planelles, B. Poon, N. P. Shah, M. L. Chen, and I. S. Chen. 1995. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69: 6304-6313.
13. Mishra, S., J. P. Mishra, and A. Kumar. 2007. Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells: involvement of antiapoptotic BCL2 and c-IAP1 genes. J. Biol. Chem. 282: 4288-4300. (Pubitemid 47100979)
14. Ayyavoo, V., S. Mahalingam, Y. Rafaeli, S. Kudchodkar, D. Chang, T. Nagashunmugam, W. V. Williams, and D. B. Weiner. 1997. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro. J. Leukoc. Biol. 62: 93-99. (Pubitemid 27321746)
15. Piller, S. C., P. Jans, P. W. Gage, and D. A. Jans. 1998. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc. Natl. Acad. Sci. USA 95: 4595-4600. (Pubitemid 28207958)
16. Levy, D. N., Y. Refaeli, R. R. MacGregor, and D. B. Weiner. 1994. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91: 10873-10877. (Pubitemid 24349587)
17. Coeytaux, E., D. Coulaud, E. Le Cam, O. Danos, and A. Kichler. 2003. The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J. Biol. Chem. 278: 18110-18116. (Pubitemid 36799424)
18. Moon, H. S., and J. S. Yang. 2006. Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells. Mol. Cells 21: 7-20.
19. Sawaya, B. E., K. Khalili, J. Gordon, A. Srinivasan, M. Richardson, J. Rappaport, and S. Amini. 2000. Transdominant activity of human immunodeficiency virus type 1 Vpr with a mutation at residue R73. J. Virol. 74: 4877-4881. (Pubitemid 30237916)
20. Schüler, W., K. Wecker, H. de Rocquigny, Y. Baudat, J. Sire, and B. P. Roques. 1999. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. J. Mol. Biol. 285: 2105-2117. (Pubitemid 29078174)
21. Arunagiri, C., I. Macreadie, D. Hewish, and A. Azad. 1997. A C-terminal domain of HIV-1 accessory protein Vpr is involved in penetration, mitochondrial dysfunction and apoptosis of human CD4+ lymphocytes. Apoptosis 2: 69-76. (Pubitemid 127508895)
22. Jacotot, E., L. Ravagnan, M. Loeffler, K. F. Ferri, H. L. Vieira, N. Zamzami, P. Costantini, S. Druillennec, J. Hoebeke, J. P. Briand, et al. 2000. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191: 33-46.
23. Lombardo, E., A. Alvarez-Barrientos, B. Maroto, L. Boscá, and U. G. Knaus. 2007. TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signalling. J. Immunol. 178: 3731-3739. (Pubitemid 46417641)
24. Park, Y., S. W. Lee, and Y. C. Sung. 2002. Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3′-OH kinase pathway. J. Immunol. 168: 5-8. (Pubitemid 34014095)
25. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371. (Pubitemid 44924494)
26. Ancuta, P., A. Kamat, K. J. Kunstman, E. Y. Kim, P. Autissier, A. Wurcel, T. Zaman, D. Stone, M. Mefford, S. Morgello, et al. 2008. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3: e2516.
27. Báfica, A., C. A. Scanga, M. Schito, D. Chaussabel, and A. Sher. 2004. Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J. Immunol. 172: 7229-7234. (Pubitemid 38747580)
28. Lawn, S. D. 2004. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J. Infect. 48: 1-12. (Pubitemid 38072197)
29. Merritt, J. E., W. P. Armstrong, C. D. Benham, T. J. Hallam, R. Jacob, A. Jaxa- Chamiec, B. K. Leigh, S. A. McCarthy, K. E. Moores, and T. J. Rink. 1990. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 271: 515-522. (Pubitemid 20344770)
30. Peppiatt, C. M., T. J. Collins, L. Mackenzie, S. J. Conway, A. B. Holmes, M. D. Bootman, M. J. Berridge, J. T. Seo, and H. L. Roderick. 2003. 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate- induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34: 97-108. (Pubitemid 36790448)
31. Kawamura, A., and M. S. Su. 1995. Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain. J. Biol. Chem. 270: 15463-15466.
32. Mishra, J. P., S. Mishra, K. Gee, and A. Kumar. 2005. Differential involvement of calmodulin-dependent protein kinase II-activated AP-1 and c-Jun N-terminal kinase-activated EGR-1 signaling pathways in tumor necrosis factor-alpha and lipopolysaccharide-induced CD44 expression in human monocytic cells. J. Biol. Chem. 280: 26825-26837 (Pubitemid 41040716)
33. Muthumani, K., D. S. Hwang, B. M. Desai, D. Zhang, N. Dayes, D. R. Green, and D. B. Weiner. 2002. HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J. Biol. Chem. 277: 37820-37831.
34. Lum, J. J., O. J. Cohen, Z. Nie, J. G. Weaver, T. S. Gomez, X. J. Yao, D. Lynch, A. A. Pilon, N. Hawley, J. E. Kim, et al. 2003. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J. Clin. Invest. 111: 1547-1554. (Pubitemid 38063287)
35. Conti, L., P. Matarrese, B. Varano, M. C. Gauzzi, A. Sato, W. Malorni, F. Belardelli, and S. Gessani. 2000. Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J. Immunol. 165: 3293-3300.
36. Fukumori, T., H. Akari, S. Iida, S. Hata, S. Kagawa, Y. Aida, A. H. Koyama, and A. Adachi. 1998. The HIV-1 Vpr displays strong anti-apoptotic activity. FEBS Lett. 432: 17-20. (Pubitemid 28360731)
37. Said, E. A., F. P. Dupuy, L. Trautmann, Y. Zhang, Y. Shi, M. El-Far, B. J. Hill, A. Noto, P. Ancuta, Y. Peretz, et al. 2010. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 16: 452-459.
38. Deveraux, Q. L., and J. C. Reed. 1999. IAP family proteins-suppressors of apoptosis. Genes Dev. 13: 239-252.
39. Wu, H., J. Tschopp, and S. C. Lin. 2007. Smac mimetics and TNFalpha: a dangerous liaison? Cell 131: 655-658. (Pubitemid 350087206)
40. Nishihara, H., M. Hwang, S. Kizaka-Kondoh, L. Eckmann, and P. A. Insel. 2004. Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK. J. Biol. Chem. 279: 26176-26183. (Pubitemid 38798763)
41. Hu, P., Z. Han, A. D. Couvillon, and J. H. Exton. 2004. Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J. Biol. Chem. 279: 49420-49429. (Pubitemid 39625828)
42. Liu, X., M. Yao, N. Li, C. Wang, Y. Zheng, and X. Cao. 2008. CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112: 4961-4970.
43. Stull, J. T. 2001. Ca2+-dependent cell signaling through calmodulin-activated protein phosphatase and protein kinases minireview series. J. Biol. Chem. 276: 2311-2312.
44. Berridge, M. J., P. Lipp, and M. D. Bootman. 2000. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1: 11-21.
45. Kim, Y., J. S. Moon, K. S. Lee, S. Y. Park, J. Cheong, H. S. Kang, H. Y. Lee, and H. D. Kim. 2004. Ca2+/calmodulin-dependent protein phosphatase calcineurin mediates the expression of iNOS through IKK and NF-kappaB activity in LPS-stimulated mouse peritoneal macrophages and RAW 264.7 cells. Biochem. Biophys. Res. Commun. 314: 695-703. (Pubitemid 38112855)
46. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537. (Pubitemid 34441357)
47. Kuznik, A., M. Bencina, U. Svajger, M. Jeras, B. Rozman, and R. Jerala. 2011. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J. Immunol. 186: 4794-4804.
48. Nørgaard, N. N., T. Holien, S. Jönsson, H. Hella, T. Espevik, A. Sundan, and T. Standal. 2010. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis. J. Immunol. 185: 3131-3139.
49. Trevani, A. S., A. Chorny, G. Salamone, M. Vermeulen, R. Gamberale, J. Schettini, S. Raiden, and J. Geffner. 2003. Bacterial DNA activates human neutrophils by a CpG-independent pathway. Eur. J. Immunol. 33: 3164-3174. (Pubitemid 37428349)
50. Hägele, H., R. Allam, R. D. Pawar, C. A. Reichel, F. Krombach, and H. J. Anders. 2009. Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. Am. J. Pathol. 175: 1896-1904.
51. Sanjuan, M. A., N. Rao, K. T. Lai, Y. Gu, S. Sun, A. Fuchs, W. P. Fung-Leung, M. Colonna, and L. Karlsson. 2006. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J. Cell Biol. 172: 1057-1068.
52. Lester, R. T., X. D. Yao, T. B. Ball, L. R. McKinnon, R. Kaul, C. Wachihi, W. Jaoko, F. A. Plummer, and K. L. Rosenthal. 2008. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 22: 685-694. (Pubitemid 351450636)
53. Kuo, C. C., S. M. Liang, and C. M. Liang. 2006. CpG-B oligodeoxynucleotide promotes cell survival via up-regulation of Hsp70 to increase Bcl-xL and to decrease apoptosis-inducing factor translocation. J. Biol. Chem. 281: 38200-38207.
54. Zhou, Y., H. Zhen, Y. Mei, Y. Wang, J. Feng, S. Xu, and X. Fu. 2009. PI3K/AKT mediated p53 down-regulation participates in CpG DNA inhibition of spontaneous B cell apoptosis. Cell. Mol. Immunol. 6: 175-180.
55. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745. (Pubitemid 32015992)
56. Salaun, B., P. Romero, and S. Lebecque. 2007. Toll-like receptors' two-edged sword: when immunity meets apoptosis. Eur. J. Immunol. 37: 3311-3318.
57. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364. (Pubitemid 46674493)
58. Suzuki, K., A. Mori, K. J. Ishii, J. Saito, D. S. Singer, D. M. Klinman, P. R. Krause, and L. D. Kohn. 1999. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc. Natl. Acad. Sci. USA 96: 2285-2290. (Pubitemid 29117906)
59. Ishii, K. J., K. Suzuki, C. Coban, F. Takeshita, Y. Itoh, H. Matoba, L. D. Kohn, and D. M. Klinman. 2001. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167: 2602-2607. (Pubitemid 32768888)
60. Ishii, K. J., C. Coban, H. Kato, K. Takahashi, Y. Torii, F. Takeshita, H. Ludwig, G. Sutter, K. Suzuki, H. Hemmi, et al. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7: 40-48. (Pubitemid 41823867)
61. Dragoi, A. M., X. Fu, S. Ivanov, P. Zhang, L. Sheng, D. Wu, G. C. Li, and W. M. Chu. 2005. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J. 24: 779-789. (Pubitemid 40396107)
62. Gee, K., J. B. Angel, S. Mishra, M. A. Blahoianu, and A. Kumar. 2007. IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J. Immunol. 178: 798-807. (Pubitemid 46095152)
63. Letari, O., S. Nicosia, C. Chiavaroli, P. Vacher, and W. Schlegel. 1991. Activation by bacterial lipopolysaccharide causes changes in the cytosolic free calcium concentration in single peritoneal macrophages. J. Immunol. 147: 980-983.
64. Liu, J., and A. Lin. 2005. Role of JNK activation in apoptosis: a double-edged sword. Cell Res. 15: 36-42. (Pubitemid 41653963)
65. Nishina, H., K. D. Fischer, L. Radvanyi, A. Shahinian, R. Hakem, E. A. Rubie, A. Bernstein, T. W. Mak, J. R. Woodgett, and J. M. Penninger. 1997. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385: 350-353.
66. Tournier, C., P. Hess, D. D. Yang, J. Xu, T. K. Turner, A. Nimnual, D. Bar-Sagi, S. N. Jones, R. A. Flavell, and R. J. Davis. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874. (Pubitemid 30257738)
67. Deveraux, Q. L., N. Roy, H. R. Stennicke, T. Van Arsdale, Q. Zhou, S.M. Srinivasula, E. S. Alnemri, G. S. Salvesen, and J. C. Reed. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17: 2215-2223. (Pubitemid 28171907)
68. Rothe, M., M. G. Pan, W. J. Henzel, T. M. Ayres, and D. V. Goeddel. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-1252. (Pubitemid 26007814)
69. Ow, Y. P., D. R. Green, Z. Hao, and T. W. Mak. 2008. Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell Biol. 9: 532-542. (Pubitemid 351881842)
70. Bauer, M., K. Heeg, H. Wagner, and G. B. Lipford. 1999. DNA activates human immune cells through a CpG sequence-dependent manner. Immunology 97: 699-705. (Pubitemid 29356422)
71. Fiola, S., D. Gosselin, K. Takada, and J. Gosselin. 2010. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 185: 3620-3631.
72. Klinman, D. M., F. Takeshita, I. Gursel, C. Leifer, K. J. Ishii, D. Verthelyi, and M. Gursel. 2002. CpG DNA: recognition by and activation of monocytes. Microbes Infect. 4: 897-901. (Pubitemid 34775231)
73. Verthelyi, D., K. J. Ishii, M. Gursel, F. Takeshita, and D. M. Klinman. 2001. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166: 2372-2377. (Pubitemid 32173471)
74. Sahingur, S. E., X. J. Xia, S. Alamgir, K. Honma, A. Sharma, and H. A. Schenkein. 2010. DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines. Mol. Oral Microbiol. 25: 123-135.
75. Saikh, K. U., T. L. Kissner, A. Sultana, G. Ruthel, and R. G. Ulrich. 2004. Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells. J. Immunol. 173: 7426-7434. (Pubitemid 39628182)
76. LaCasse, E. C., G. G. Cherton-Horvat, K. E. Hewitt, L. J. Jerome, S. J. Morris, E. R. Kandimalla, D. Yu, H. Wang, W. Wang, R. Zhang, et al. 2006. Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis. Clin. Cancer Res. 12: 5231-5241. (Pubitemid 44453353)
77. LaCasse, E. C., E. R. Kandimalla, P. Winocour, T. Sullivan, S. Agrawal, J. W. Gillard, and J. Durkin. 2005. Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640. Ann. N. Y. Acad. Sci. 1058: 215-234.